Scheme of Arrangement Effective / Cancellation of Listing on AIM
Recommended acquisitionof Tepnel Life Sciences plc (“Tepnel”) by Gen-Probe Incorporated (“Gen-Probe”) to be effected by means of a scheme of arrangement under Part 26 of the Companies Act 2006
Further to the announcement made by Tepnel dated 7 April 2009, the Boards of Tepnel and Gen-Probe are pleased to announce that the Scheme has become effective in accordance with its terms. The listing of Tepnel Shares on AIM has been cancelled with effect from 7.00 am on 8 April 2009. The consideration due to Scheme Shareholders will be sent no later than 14 days after the Effective Date.
Any capitalised term used but not defined in this announcement has the same meaning as is given to it in the Scheme document sent to shareholders on 21 February 2009.
